[ad_1]
The Biontech “Made in Germany” vaccine is already being administered in Great Britain and the United States. Canada, Bahrain, Saudi Arabia, Mexico and now Kuwait also granted emergency approval of the vaccine. But citizens in Germany still have to wait for approval from the European Medicines Agency (EMA).
Federal Minister of Health, Jens Spahn (CDU), demanded in the change of the Corona summit that the approval of the EMA be carried out as soon as possible. Now he pressed the European authority again on Twitter. “A review of the data and approval from the EMA should take place as soon as possible,” he wrote in one of the three tweets.
And furthermore: “It is also about citizens’ confidence in the European Union’s ability to act. The federal and state governments are as of December 15. Ready to use in the field: The first vaccination doses are practically ready and can be vaccinated immediately after approval. “
In plain language: Germany can start now, only the EU is wasting time.
In a third tweet, Spahn makes an urgent appeal: “Every day that we can start vaccinating earlier, it reduces suffering and protects the particularly vulnerable.”
Because: Germany would also have been significantly faster in a single national approval process, Spahn said. BILD learned this from the participants at the Corona conference.
So the Germans need patience. According to information from BILD, the vaccination process in Germany will also be delayed because manufacturers are not moving as quickly as expected. At the moment it is not without problems to receive doses of vaccination, said Federal Health Minister Jens Spahn (40, CDU) during the conference call with the Chancellor and the country’s leaders.
Specifically: Spahn expects only 3-4 million doses of vaccines by the end of January, in part because it takes longer to produce at Biontech / Pfizer.
